1Kang YH, Park C J, Seo E J, et al. Polymerase chain reaction-based diagnceis of bone marrow involvement in 170 case of non-Hodgkin lymphoma[ J]. Cancer,2002,4(12) :3073-3082.
3Crotty PL,Smith BR,Tallini G. Morpbologic, immunophenotypic and molecular evaluation of bone marrow involvement in non-Hodgkin's lympboma[ J]. Diagn Mol Pathol, 1998,7 (2) :90-95.
4Thiele J,Zirbes T K,Kvasnicka HM ,et al. Focal lymphoid aggregates (nodules) in bone marrow biopsies: differentiation between benign hyperplasia and malignant lymphoma-a practical guideline[J]. J Clin Pathol, 1999,52 (4) :294-300.
7[ No authors listed]. A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin' s lymphoma. The non-Hodgkin' s Lymphoma Classification Project. Blood, 1997, 89: 3909-3918.
8Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on A dvanced Hodgkin ' s disease. N Engl J Med, 1998,339 : 1506-1514.
9Gallamini A, Stelitano C, Calvi R, et al. Peripheral T-cell lymphoma unspecified (PTCL-U) : a new prognostic model from a retrospective muhicentric clinical study. Blood ,2004,103 : 2474-2479.
